- Home
- Labeler Index
- Catalent Pharma Solutions, Llc
- 11014-0449
- NDC Crossover: 11014-0449 Ruxolitinib
NDC Crossover 11014-0449 Ruxolitinib
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ruxolitinib
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 11014-0449 – Ruxolitinib, drug for further processing. This list includes other cross-matching products that share:
- The same product name: Ruxolitinib
- OR Generic name: Ruxolitinib
- AND the same Administration Route:
- OR Dosage Form: tablet
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
50881-005 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
50881-010 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
50881-015 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
50881-020 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
50881-025 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |